ACADIA Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 21, 2016
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the JMP Securities Life Sciences Conference on Tuesday, June 21, 2016, at 9:00 a.m. Eastern Time in New York City. A live webcast of ACADIA’s presentation will be accessible on the company’s website, www.acadia-pharm
